1. Home
  2. KZR
  3. KZR News

Latest Kezar Life Sciences Inc. (KZR) News on November 4, 2025

KZR

MT Newswires

18 days ago

William Blair Downgrades Kezar Life Sciences to Market Perform From Outperform

KZR

MT Newswires

18 days ago

Jefferies & Co Downgrades Kezar Life Sciences to Hold From Buy, Adjusts Price Target to $7 From $18

KZR

MT Newswires

18 days ago

Top Premarket Gainers

KZR

MT Newswires

19 days ago

Kezar Life Sciences to Explore Strategic Options, Cut Jobs After FDA Setback; Shares Jump After Hours

Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives
KZR

Business Wire

19 days ago

Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives

Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
KZR

Business Wire

5 months ago

Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference

Kezar Life Sciences (KZR) Upgraded to Buy: What Does It Mean for the Stock?
KZR

Zacks

5 months ago

Kezar Life Sciences (KZR) Upgraded to Buy: What Does It Mean for the Stock?

Kezar Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
KZR

Business Wire

6 months ago

Kezar Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

Kezar Life Sciences Announces Positive Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis (AIH) and Reports Fourth Quarter and Year End 2024 Financial Results
KZR

Business Wire

7 months ago

Kezar Life Sciences Announces Positive Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis (AIH) and Reports Fourth Quarter and Year End 2024 Financial Results

Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025
KZR

Business Wire

7 months ago

Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025

Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025
KZR

Business Wire

9 months ago

Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025

KZR

MT Newswires

9 months ago

Kezar Life Sciences Files $400 Million Mixed Securities Shelf

Kezar struck again with second FDA hold
KZR

Clinical Trials Arena

a year ago

Kezar struck again with second FDA hold

KZR

MT Newswires

a year ago

Kezar Life Sciences to Implement 1-for-10 Reverse Stock Split

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split
KZR

Business Wire

a year ago

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

Kezar Life Sciences discontinues lupus nephritis programme after fatalities
KZR

Clinical Trials Arena

a year ago

Kezar Life Sciences discontinues lupus nephritis programme after fatalities

KZR

MT Newswires

a year ago

Kezar Life Sciences Gets Nod to Proceed With Autoimmune Hepatitis Trial; Ends Lupus Nephritis Study

Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study
KZR

Benzinga

a year ago

Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study

KZR

MT Newswires

a year ago

Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan

Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan
KZR

Business Wire

a year ago

Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan

Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update
KZR

Business Wire

a year ago

Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update

What Makes Kezar Life Sciences (KZR) a New Buy Stock
KZR

Zacks

a year ago

What Makes Kezar Life Sciences (KZR) a New Buy Stock

KZR

MT Newswires

a year ago

Kezar Life Sciences Receives Takeover Proposal From Concentra Biosciences

Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal
KZR

Business Wire

a year ago

Kezar Confirms Receipt of Unsolicited, Non-Binding Acquisition Proposal

TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Kezar Life Sciences Inc
KZR

GuruFocus.com

a year ago

TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Kezar Life Sciences Inc

FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths
KZR

Benzinga

a year ago

FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths

FDA places hold on Kezar Life Sciences’ trial for lupus nephritis treatment
KZR

Clinical Trials Arena

a year ago

FDA places hold on Kezar Life Sciences’ trial for lupus nephritis treatment

Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis
KZR

Business Wire

a year ago

Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis

Kezar Life Sciences suspends subject enrolment in trial of lupus nephritis drug
KZR

Clinical Trials Arena

a year ago

Kezar Life Sciences suspends subject enrolment in trial of lupus nephritis drug

KZR

MT Newswires

a year ago

Kezar Life Sciences Suspends Enrollment, Dosing in Phase 2b Trial of Zetomipzomib in Active Lupus Nephritis Patients

Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
KZR

Business Wire

a year ago

Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients

Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
KZR

Business Wire

a year ago

Kezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Kezar stalls solid tumour trial to focus on autoimmune disease candidate
KZR

Pharmaceutical Technology

a year ago

Kezar stalls solid tumour trial to focus on autoimmune disease candidate

Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
KZR

Business Wire

a year ago

Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
KZR

Business Wire

a year ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
KZR

Business Wire

a year ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
KZR

Business Wire

a year ago

Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference

Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
KZR

Business Wire

a year ago

Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
KZR

Business Wire

a year ago

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin
KZR

Insider Monkey

2 years ago

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
KZR

Business Wire

2 years ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
KZR

Business Wire

2 years ago

Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
KZR

Business Wire

2 years ago

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
KZR

Business Wire

2 years ago

Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
KZR

Business Wire

2 years ago

Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
KZR

InvestorPlace

2 years ago

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond

3 Penny Stocks Poised for an Unbelievable 1,000% Jump
KZR

InvestorPlace

2 years ago

3 Penny Stocks Poised for an Unbelievable 1,000% Jump

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
KZR

PR Newswire

2 years ago

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
KZR

PR Newswire

2 years ago

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

Panacea Financial Named Exclusive Practice Finance Provider for American Dental Association Members across the United States
KZR

PR Newswire

2 years ago

Panacea Financial Named Exclusive Practice Finance Provider for American Dental Association Members across the United States

Primis Financial Corp (FRST) Reports Notable Improvement in Q4 2023 Earnings
KZR

GuruFocus.com

2 years ago

Primis Financial Corp (FRST) Reports Notable Improvement in Q4 2023 Earnings

Velo3D Announces Key Strategic Priorities for Growth in 2024
KZR

Business Wire

2 years ago

Velo3D Announces Key Strategic Priorities for Growth in 2024

Hanover Bancorp, Inc. Reports Earnings for the Fourth Calendar Quarter highlighted by Increased Net Income and Net Interest Income and Strong Non-interest Income
KZR

GlobeNewswire

2 years ago

Hanover Bancorp, Inc. Reports Earnings for the Fourth Calendar Quarter highlighted by Increased Net Income and Net Interest Income and Strong Non-interest Income

Pixelworks Collaborates with OnePlus to Deliver Unparalleled Gaming Experience on OnePlus 12 Global Version
KZR

PR Newswire

2 years ago

Pixelworks Collaborates with OnePlus to Deliver Unparalleled Gaming Experience on OnePlus 12 Global Version

Shareholders in Lake Shore Bancorp (NASDAQ:LSBK) are in the red if they invested five years ago
KZR

Simply Wall St.

2 years ago

Shareholders in Lake Shore Bancorp (NASDAQ:LSBK) are in the red if they invested five years ago

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
KZR

GlobeNewswire

2 years ago

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

While institutions own 33% of Lands' End, Inc. (NASDAQ:LE), individual investors are its largest shareholders with 57% ownership
KZR

Simply Wall St.

2 years ago

While institutions own 33% of Lands' End, Inc. (NASDAQ:LE), individual investors are its largest shareholders with 57% ownership

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer
KZR

GlobeNewswire

2 years ago

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference
KZR

PR Newswire

2 years ago

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

Safe Bulkers, Inc.'s (NYSE:SB) top owners are individual investors with 37% stake, while 26% is held by insiders
KZR

Simply Wall St.

2 years ago

Safe Bulkers, Inc.'s (NYSE:SB) top owners are individual investors with 37% stake, while 26% is held by insiders

BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease
KZR

PR Newswire

2 years ago

BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease

KZR

Business Wire

2 years ago

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

KZR

GuruFocus.com

2 years ago

Shimmick Corp (SHIM) Reports Solid Earnings Amidst Strategic Shifts

KZR

GlobeNewswire

2 years ago

Shimmick Corp. Announces Third Quarter 2023 Results

Gevo VP of Government Relations Lindsay Fitzgerald and VP of Finance & Strategy Eric Frey to Participate in a Water Tower Research Fireside Chat on Tuesday, December 19th at 10:00 am ET
KZR

GlobeNewswire

2 years ago

Gevo VP of Government Relations Lindsay Fitzgerald and VP of Finance & Strategy Eric Frey to Participate in a Water Tower Research Fireside Chat on Tuesday, December 19th at 10:00 am ET

Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth
KZR

InvestorPlace

2 years ago

Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth

Don't Race Out To Buy First Guaranty Bancshares, Inc. (NASDAQ:FGBI) Just Because It's Going Ex-Dividend
KZR

Simply Wall St.

2 years ago

Don't Race Out To Buy First Guaranty Bancshares, Inc. (NASDAQ:FGBI) Just Because It's Going Ex-Dividend

Perfect Corp. Initiates Tender Offer: A Deep Dive Into What This Means For Investors
KZR

ACCESSWIRE

2 years ago

Perfect Corp. Initiates Tender Offer: A Deep Dive Into What This Means For Investors

KZR

GlobeNewswire

2 years ago

Shimmick Corporation Appoints Joe Del Guercio to Board of Directors

Shareholders in El Pollo Loco Holdings (NASDAQ:LOCO) are in the red if they invested three years ago
KZR

Simply Wall St.

2 years ago

Shareholders in El Pollo Loco Holdings (NASDAQ:LOCO) are in the red if they invested three years ago

KZR

GlobeNewswire

2 years ago

Shimmick Corporation Announces Third Quarter 2023 Earnings Release Date and Conference Call

Those who invested in Full House Resorts (NASDAQ:FLL) five years ago are up 145%
KZR

Simply Wall St.

2 years ago

Those who invested in Full House Resorts (NASDAQ:FLL) five years ago are up 145%

Opthea to Present at the FLORetina 2023 Congress
KZR

GlobeNewswire

2 years ago

Opthea to Present at the FLORetina 2023 Congress

Sky Harbour Group Announces the Second Closing of its Private Equity Placement with an Altai Capital Investment Vehicle for an Additional Aggregate Consideration of $15,000,000
KZR

Business Wire

2 years ago

Sky Harbour Group Announces the Second Closing of its Private Equity Placement with an Altai Capital Investment Vehicle for an Additional Aggregate Consideration of $15,000,000

KZR

News Direct

2 years ago

Renovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024

Civeo (CVEO)'s Technical Outlook is Bright After Key Golden Cross
KZR

Zacks

2 years ago

Civeo (CVEO)'s Technical Outlook is Bright After Key Golden Cross

Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference
KZR

Business Wire

2 years ago

Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

BioLineRx Ltd. (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript
KZR

Insider Monkey

2 years ago

BioLineRx Ltd. (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript

Renovaro BioSciences Eyes Opportunity in Precision Medicine Market
KZR

NewMediaWire

2 years ago

Renovaro BioSciences Eyes Opportunity in Precision Medicine Market

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
KZR

GlobeNewswire

2 years ago

EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference

Why Latham Group, Inc. (NASDAQ:SWIM) Could Be Worth Watching
KZR

Simply Wall St.

2 years ago

Why Latham Group, Inc. (NASDAQ:SWIM) Could Be Worth Watching

Renovaro Biosciences CEO Provides Update on Combination with GEDiCube
KZR

NewMediaWire

2 years ago

Renovaro Biosciences CEO Provides Update on Combination with GEDiCube

KZR

GlobeNewswire

2 years ago

Shimmick Corporation Announces Pricing of Initial Public Offering

Lument Finance Trust Reports Third Quarter Results
KZR

PR Newswire

2 years ago

Lument Finance Trust Reports Third Quarter Results

Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
KZR

Business Wire

2 years ago

Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Hamilton Beach Brands Holding (NYSE:HBB) Has Affirmed Its Dividend Of $0.11
KZR

Simply Wall St.

2 years ago

Hamilton Beach Brands Holding (NYSE:HBB) Has Affirmed Its Dividend Of $0.11

A Look At The Intrinsic Value Of Tredegar Corporation (NYSE:TG)
KZR

Simply Wall St.

2 years ago

A Look At The Intrinsic Value Of Tredegar Corporation (NYSE:TG)

WESTERN COPPER AND GOLD PROVIDES GUIDANCE ON ENVIRONMENTAL AND SOCIO-ECONOMIC EFFECTS STATEMENT SUBMISSION AND INFRASTRUCTURE UPDATE
KZR

CNW Group

2 years ago

WESTERN COPPER AND GOLD PROVIDES GUIDANCE ON ENVIRONMENTAL AND SOCIO-ECONOMIC EFFECTS STATEMENT SUBMISSION AND INFRASTRUCTURE UPDATE

Smith-Midland Corp (SMID) Reports Significant Revenue and Net Income Growth in Q3 2023
KZR

GuruFocus.com

2 years ago

Smith-Midland Corp (SMID) Reports Significant Revenue and Net Income Growth in Q3 2023

Share on Social Networks: